Amphotericin B deoxycholate for candidiasis in intensive care unit patients revisited: medical, ethical, and financial implications

Am J Respir Crit Care Med. 2013 Mar 15;187(6):661-3. doi: 10.1164/ajrccm.187.6.661.
No abstract available

Publication types

  • Letter

MeSH terms

  • Amphotericin B / adverse effects
  • Amphotericin B / therapeutic use*
  • Antifungal Agents / adverse effects
  • Antifungal Agents / therapeutic use*
  • Candidiasis / drug therapy*
  • Creatinine / blood
  • Critical Illness
  • Cross Infection / drug therapy*
  • Deoxycholic Acid / adverse effects
  • Deoxycholic Acid / therapeutic use*
  • Drug Combinations
  • Fluconazole / therapeutic use
  • Humans
  • Intensive Care Units
  • Practice Patterns, Physicians'
  • Renal Insufficiency / chemically induced

Substances

  • Antifungal Agents
  • Drug Combinations
  • Deoxycholic Acid
  • Amphotericin B
  • amphotericin B, deoxycholate drug combination
  • Fluconazole
  • Creatinine